Skip to main
ABSI

Absci Corp (ABSI) Stock Forecast & Price Target

Absci Corp (ABSI) Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 50%
Buy 50%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Absci Corp's lead product candidate, ABS-201, demonstrates promising potential for significant hair growth in patients, with management indicating that achieving a target of at least 40 hairs/cm² would position it competitively in the market. The anticipated initial efficacy data from the MAD study, expected in the second half of 2026, represents a crucial milestone that could further validate the product's therapeutic capabilities and drive investor interest. The updated real net present value (rNPV) of $1.6 billion, an increase from the previous $1.4 billion, reflects growing confidence in the product's commercial viability and strong preclinical evidence supporting its mechanism of action.

Bears say

Absci Corp faces multiple risks that could adversely impact its stock performance, including challenges related to partnerships, technology, clinical development, regulatory hurdles, and potential competition. Additionally, there are significant concerns surrounding the company's ability to maintain and protect its intellectual property while navigating a landscape that may also involve legal complexities. The existing high treatment burden associated with their lead product candidate, ABS-201, may result in patient attrition as individuals gravitate towards more permanent solutions, which could hinder commercial viability and future revenue growth.

Absci Corp (ABSI) has been analyzed by 4 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 50% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Absci Corp and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Absci Corp (ABSI) Forecast

Analysts have given Absci Corp (ABSI) a Buy based on their latest research and market trends.

According to 4 analysts, Absci Corp (ABSI) has a Buy consensus rating as of Apr 6, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $7.47, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $7.47, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Absci Corp (ABSI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.